
Sign up to save your podcasts
Or
Welcome back to the Oncology Brothers podcast! In this episode, Drs. Rahul and Rohit Gosain are joined by world-renowned medical oncologist Dr. Monty Pal from the City of Hope. Together, they dived deep into the management of side effects associated with tyrosine kinase inhibitors (TKIs) and HIF-2 alpha inhibitors used in treating renal cell carcinoma (RCC).
Episode Highlights:
Join us as we emphasized the importance of maintaining quality of life for patients undergoing treatment for metastatic RCC.
Follow us on social media:
Don't forget to check out our other episodes for more insights on treatment algorithms, conference highlights, and challenging cases from the community.
4.8
4040 ratings
Welcome back to the Oncology Brothers podcast! In this episode, Drs. Rahul and Rohit Gosain are joined by world-renowned medical oncologist Dr. Monty Pal from the City of Hope. Together, they dived deep into the management of side effects associated with tyrosine kinase inhibitors (TKIs) and HIF-2 alpha inhibitors used in treating renal cell carcinoma (RCC).
Episode Highlights:
Join us as we emphasized the importance of maintaining quality of life for patients undergoing treatment for metastatic RCC.
Follow us on social media:
Don't forget to check out our other episodes for more insights on treatment algorithms, conference highlights, and challenging cases from the community.
320 Listeners
39 Listeners
116 Listeners
57 Listeners
289 Listeners
2,429 Listeners
3,334 Listeners
1,143 Listeners
200 Listeners
184 Listeners
44 Listeners
21 Listeners
189 Listeners
56 Listeners
185 Listeners